Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open Phase II Trial of E4 in Systemic Juvenile Idiopathic Arthritis
KCT0005867Phase 2Recruiting
- Sponsor
- Bionoxx
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of estetrol in systemic juvenile idiopathic arthritis (SJIA), sponsored by Bionoxx. Started Feb 2023; status: recruiting.
02
Drugs
estetrol
03
Conditions
systemic juvenile idiopathic arthritis (SJIA)
Beyond the preview
Go deeper on KCT0005867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0005867.